مباشر

FierceBiotechJapan, South Korea challenge the West’s place in research rankings: report Endpoints NewsCMS seeks to close Medicare negotiation 'loophole'Endpoints NewsFDA plans to keep Makary priorities on trials, China, deputy says Clinical OMICsTwo Women, One Mission: Closing the Gap Between Cancer Science and Survival Endpoints NewsTakeda fortifies orexin potential with more Phase 3 data Endpoints NewsElicio’s KRAS cancer vaccine fails in Phase 2, shares plummet FierceBiotechAmid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant Endpoints NewsGan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data FierceBiotechAmgen loses in Harbour antibody patent case, ordered to pay $20M+FierceBiotechIntellia touts ‘paradigm-shifting’ phase 3 data for one-time HAE treatment BioWorldElicio phase II results in pancreatic cancer wreck shares BioWorldBiggest gainers and losers for June 8-12, 2026

Clinical OMICs ١٥ يونيو ٢٠٢٦

Rewriting Cancer Care Through Epigenetics

From brain-tumor classification to liquid biopsies and gene-silencing therapies, epigenetics is reshaping precision medicine in oncology and more. The post Rewr...

From brain-tumor classification to liquid biopsies and gene-silencing therapies, epigenetics is reshaping precision medicine in oncology and more. The post Rewriting Cancer Care Through Epigenetics appeared first on Inside Precision Medicine .